trending Market Intelligence /marketintelligence/en/news-insights/trending/iaa8cRmDU5GpeLUAADLHIw2 content esgSubNav
In This List

Azaya Therapeutics to sell Cytori shares in secondary offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Azaya Therapeutics to sell Cytori shares in secondary offering

Azaya Therapeutics Inc. plans to sell all the Cytori Therapeutics Inc. shares it owns.

The company will sell 1,173,241 Cytori shares at a proposed maximum aggregate offering price of $1.62 apiece for $1.9 million in proceeds. Cytori will receive no proceeds from the sale.

Cytori previously issued the shares when it acquired certain assets from Azaya Therapeutics.